A Study to Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1

NCT04152200 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Hyperoxaluria Type 1
Primary Hyperoxaluria

Interventions

DRUG: Lumasiran

Sponsor

Alnylam Pharmaceuticals